Hover a dot or row, or tab through the dots · bars scaled to the largest round ($100M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-334811
First filed2019-03-14
Latest2019-03-14
Sought$30M
Sold$30M
Investors1
Exemptions506(b)
021-329063
First filed2018-12-27
Latest2018-12-27
Sought$30M
Sold$30M
Investors1
Exemptions506(b)
021-284841
First filed2017-04-14
Latest2017-04-14
Sought$5M
Sold$5M
Investors24
Exemptions506(b)
021-272465
First filed2016-10-14
Latest2016-10-14
Sought$4.3M
Sold$4.3M
Investors1
Exemptions506(b)
021-255793
First filed2016-01-22
Latest2016-01-22
Sought$57.3M
Sold$57.3M
Investors125
Exemptions506(b)
021-247396
First filed2015-09-11
Latest2015-09-11
Sought$100M
Sold$100M
Investors1
Exemptions506(b)
021-241002
First filed2015-06-03
Latest2015-06-03
Sought$75M
Sold$75M
Investors1
Exemptions506(b)
Who backs NantCell, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2019-03-14
Related persons
Name
Relationship
Patrick Shoon-Shiong
RelationshipExecutive Officer, Director
Facts
As its latest Form D states them
Industry
Other Health Care
State
California (CA)
Exemptions
Rule 506(b)
First filed
2015-06-03
Latest filing
2019-03-14
Who backs NantCell, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)